|
Research Funding Revenues
UHN Core Research Funding
(in thousands of dollars) |
|
Princess Margaret Hospital Foundation
|
15,341 |
|
Toronto General & Western Hospital Foundation |
2,502 |
Arthritis & Autoimmunity Research Centre Foundation |
1,259 |
|
Ministry of Health & Long Term Care |
2,850 |
|
Recoveries |
7,652 |
|
Investment income |
2,814 |
|
Other |
13,213 |
|
TOTAL |
45,631 |
|
|
UHN External Research Funding
(in thousands of dollars) |
|
|
Operating Grants |
74,719 |
|
Infrastructure / Maintenance Awards |
24,339 |
Clinical Studies |
17,997 |
|
Other |
9,759 |
|
Career / Traineeship Awards |
7,642 |
|
Corporate Contracts |
7,225 |
|
TOTAL |
141,681 |
|
|
| |
Major Sources of External Funding
(in thousands of dollars) |
|
|
Canadian Institutes of Health Research |
24,653 |
|
Canada Foundation for Innovation/OIT |
22,318 |
National Cancer Institute of Canada |
7,275 |
|
National Institutes of Health (US) |
6,843 |
|
Ontario Institute for Cancer Research |
4,581 |
|
Heart and Stroke Foundations |
3,973 |
| Ontario Genomics Institute |
2,726 |
| Canada Research Chairs Program |
2,556 |
|
All figures represent fiscal year 2006/07 and include Ontario Cancer Institute (Princess Margaret Hospital); Toronto General Research Institute (Toronto General Hospital); and Toronto Western Research Institute (Toronto Western Hospital).
These figures have been provided by UHN Research Financial Services and Research Grant and Contract Services. These figures have not been audited. However, they have been included in the overall UHN statements and, as a result, have been subjected to audit procedures deemed appropriate by auditors in order to determine their overall reasonableness. |
|
|
| |
External Agencies Funding UHN Research |
|
|
|
P-Z |
Full Listing
|
Parkinson Society Canada
PDL BioPharma
Pfizer
Pharmacyclics
PharmLink
Philips Electronics
Photopharmacia
Physicians' Research and Education Network
Physicians' Services Inc. Foundation
Pierre Fabre Medicament
Procter & Gamble
Prostate Cancer Research Foundation of Canada
Proteolix
Queen's University
RaySearch Medical
Reata Pharmaceuticals
Rett Syndrome Research Foundation
Rheuminations
Roche
Roche Diagnostics GMBH
Roswell Park Cancer Institute
Royal College of Physicians and Surgeons of Canada
SAIC Frederick
Samuel Waxman Cancer Research Foundation
Sangamo Biosciences
Sanofi Winthrop
Sanofi-aventis Canada
Sanofi-Synthelabo Canada
Schering Canada
Sepsis
Serono Canada
Serono International
Servier Canada
Signal Pharmaceuticals
Society of University Surgeons
Solutions By Sequence
Spiration
St. Michael's Hospital
Stanley Medical Research Institute
Steba Beheer N.V.
Stryker
Sunnybrook Health Sciences Centre
Susan G. Komen Breast Cancer Foundation
Systemix Institute
Taro Pharmaceuticals
Taylor & Francis Group
Teva Neuroscience
Thoratec
Tibotec Pharmaceuticals
Toronto Medical Laboratories
Transition Therapeutics
Trillium Therapeutics
Twinstrand Therapeutics
Unilever
United Paragon Associates
University of British Columbia
University of Calgary
University of Cincinnati
University of Pittsburgh Medical Center
University of Toronto
University of Utah
University Renal Research & Education Association
US Army Department of Defense
US Army Medical Research Acquisition Activity
Valeant Pharmaceutical International
Varian Medical Systems
Vasogen
Vion Pharmaceuticals
Vitamin D Society
Viventia Biotech
Women's College Hospital
Wyeth
Xillix Technologies
Yale University
YM Biosciences
York University
Younger Foundation
YYZ Pharmatech
ZIOPHARM Oncology |
|
